Improzone

Improzo

0,0 (0)
Yaşam Bilimleri
Her Ay

You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.

20 May

Season 2 Episode 4.2 CRM Reimagined: Present Day Realities

Season 2 Miniseries Episode 4.2 is officially live.New Improzone Podcast EpisodeIn this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to unpack the present-day realities of CRM transformation, where life sciences, data, and technology intersect, and where teams are now being forced to make some of their most critical platform decisions.Key takeaways:- Why CRM decisions today are no longer just about features, but about entire enterprise ecosystems- The real trade-offs between Veeva Vault CRM and Salesforce Life Sciences Cloud in pharma environments- How platform depth across clinical, regulatory, and commercial systems is reshaping migration complexity- The hidden cost layers from integrations to change management, that often define success or failure- How AI-driven narratives from both platforms are influencing (but not yet proving) real-world outcomes- Why early-stage biotech companies are increasingly locking into ecosystems like Veeva Basics from day oneA grounded, real-world conversation on what’s actually happening inside CRM decision rooms today, the pressure, the complexity, and the trade-offs that don’t always show up in presentations.#improzonepodcast #crm #lifesciences #digitaltransformation #customerexperience #pharmatech #aiinhealthcare #improzo

24 dk.
30 Nis

Season 2 Episode 4.1 CRM Reimagined: Looking at the History with Jason Harlander from Improzo

Season 2 Episode 4.1 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore the origins of CRM in life sciences and how early decisions continue to shape the industry today. Key takeaways: * How Salesforce started as a SaaS disruptor and built the foundation for modern CRM * Why Veeva’s vertical-first approach transformed pharma CRM adoption * The role of force.com in accelerating innovation without building from scratch * How early strategic decisions helped Veeva capture massive market share * What the Veeva Salesforce split means for the industry today A grounded conversation on where CRM really came from and why understanding its history is key to making better decisions moving forward.

19 dk.
26 Mar

Season 2 Episode 3: Perception vs. Perspective: Rethinking AI Adoption in Biopharma

New Improzone Podcast Episode Jane Urban sits down with Navdeep Singh (AWS Customer Success Leader) to explore Perception vs. Perspective: Rethinking AI Adoption in Biopharma, a conversation that goes beyond the hype to examine how AI is actually being adopted across life sciences organizations today. Key takeaways: • The gap between how AI is perceived and how it performs in real-world settings • Why adoption challenges are often operational, not technical • The importance of context, governance, and decision ownership in AI systems • Moving beyond pilots toward execution-focused AI strategies • Why human judgment continues to play a critical role alongside AI A grounded, practical conversation on what it really takes to make AI work in biopharma not just in theory, but in execution. #ImprozonePodcast #AIForLifeSciences #Biopharma #AIAdoption #AgenticAI #ImprozoThoughtLeadership

26 dk.
18 Şub

Season 2 Episode 2: How MDM and AI are Evolving Together

New Improzone Podcast Episode Jane Urban sits down with Stephen Gatchell (Ortecha) to explore how MDM and AI are evolving together — and why the “golden record” mindset no longer works at scale.Key takeaways:• MDM is shifting from rigid systems of truth to context-driven data philosophies• AI-enabled documentation, observability, and metadata enrichment are changing how data is mastered• Small language models and modular agents outperform one-size-fits-all AI• The real power is human + AI, not automation alone• Entry-level work is changing — but critical thinking and communication matter more than ever A practical, honest conversation about what’s actually working — and what’s next.#ImprozonePodcast #AIForLifeSciences #DataStrategy #MDM #AgenticAI #ImprozoThoughtLeadership

26 dk.
29 Oca

Season 2 Episode 1: Scaling AI Across the Enterprise

Most biotech companies are stuck in "pilot purgatory" with Generative AI. But moving from a fun experiment to a scalable, enterprise-grade solution requires more than just a software license, it demands a fundamental shift in how IT partners with Legal, QA, and Regulatory teams. In the Season 2 premiere of The Improzone, host Jane Urban sits down with Andrew Schwartz (Head of Global IT, KalVista Pharmaceuticals) to break down the roadmap for scaling AI across the enterprise. In this episode, we cover: Shadow IT vs. Enterprise Strategy: Why moving off personal ChatGPT accounts is the first step to security. The "Human-in-the-Loop": How to deploy Agentic AI that assists rather than replaces. Cross-Functional Governance: How to get Legal and QA to say "Yes" to innovation. If you are leading digital transformation in life sciences, this is your blueprint for 2026. #GenerativeAI #LifeSciences #PharmaAI #BiotechInnovation #EnterpriseAI #DigitalTransformation #KalVista #TheImprozone #AIgovernance #Improzo

53 dk.
17.12.2025

Episode 4.4 - The AI Adoption Arc: Externally Facing AI Tools

We are LIVE with the finale of our mini-series! In Episode 4.4 - The AI Adoption Arc, we shift the focus outward to exploring Externally Facing AI Tools.While internal efficiencies are critical, the true competitive advantage in Life Sciences lies in how AI reshapes your customer touchpoints. From personalized HCP engagement to responsive patient support, we unpack how to deploy AI that builds trust rather than just cutting costs.Don’t leave the most visible part of your business in the analog age.#Improzo #LifeSciences #AIAdoption #PharmaTech #CustomerExperience #GenerativeAI #DigitalTransformation

23 dk.
03.12.2025

Season 1 Episode 4.3 - Using Third-Party Tools with AI Inside

In the latest episode of The Improzone Mini-Series 4.3, we explore the critical shift from legal compliance to technical verification. Key Insight: Treat your third-party AI like an "over-eager intern"—talented, capable, but lacking the judgment to represent your brand without supervision. In this episode, we unpack: - The Limits of Questionnaires: Why paper surveys fail to catch GenAI hallucinations. - Brand vs. Security: Why a secure bot can still be toxic. - Continuous Validation: Why a one-time pen test is already obsolete. Join Jane Urban and Nathan Trueblood for a masterclass in AI procurement safety. #ArtificialIntelligence #PharmaTech #DigitalHealth #RiskManagement #AIEthics #VendorManagement #TechLeadership #EnkryptAI #Improzo

21 dk.
26.11.2025

Season 1 Episode 4.2 The AI Adoption Arc: The Build Stage & The Risk of Prompt Hacking

In Part 2 of The AI Adoption Arc, we break down the critical shift to building proprietary LLM agents. Discover the severe security vulnerabilities introduced by prompt injection and data contamination in custom workflows. Learn how to implement use-case specific guardrails to achieve measurable, compliant scale. #AICapability #DigitalTransformation #LifeSciencesTech #ComplianceByDesign #AIStrategy #Improzo #ImprozonePodcast

19 dk.
13.11.2025

Season 1 Episode 4.1 - Pharma’s First Steps with AI, featuring Jane Urban & Nathan Trueblood

How do life sciences organizations move from AI buzzwords to business impact? In this episode of The Improzone, discover how to start small, build trust, and make AI your co-pilot for smarter pharma decisions.Watch now and learn how real innovation begins. #Improzone #AIInPharma #Improzo #LifeSciencesAI #HealthcareInnovation #AIAdoption #DataDrivenDecisions

17 dk.
15.10.2025

Season 1 Episode 3 - Generative AI in Life Sciences: Medical & Commercial Transformations

Here comes our 3rd podcast of the ImproZone! Join host Jane Urban and Indy Sawhney (AWS) as this episode speaks directly on the execution of Generative AI in Life Sciences. We dive into how #GenerativeAI is: Enhancing human performance in R&D and commercial roles. Enabling faster, smarter insights across global biopharma operations. Moving from AI strategy to an actionable execution plan. Listen now to unlock your next steps in #CommercialTransformation! #LifeSciences #Biopharma #GenAI #DigitalTransformation #Execution #Improzo #Improzone

37 dk.
18.09.2025

Season 1 Episode 2 – Securing the Future: AI, Privacy and Partnership in Lifesciences

New Podcast Episode of The Improzone! Can AI and privacy coexist in pharma? In this episode, our host Jane Urban talks to Improzo's Abhishek Trigunait and Enkrypt AI's Nathan Trueblood about making responsible AI a reality. We're exploring the future of AI in Lifesciences, focusing on data privacy, compliance, and the power of strategic partnerships. Watch Now and secure the future of your AI strategy. To know more about us, visit www.improzo.com #AI #Lifesciences #Biotech #HealthTech #Podcast #Improzone #EnkryptAI #Innovation #Pharma #Improzo

50 dk.
20.08.2025

Season 1 Episode 1: AI That Actually Gets Used — A Startup’s Take on Pharma Innovation

You’re about to enter a new dimension—where AI doesn’t just sit in dashboards, it makes decisions. Improzo CEO Inderpreet Kambo joins host Jane Urban to talk about building modular, pharma-native AI agents that work where users already are—from Veeva to Salesforce. Why do most pharma AI programs fail? And how do you go from “insight” to actual impact? Step into The Improzone. 🎧 Listen now.

36 dk.

12 Bölüm

You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.

Yaratıcı

Improzo
Aktif Yıllar

2025 - 2026
Bölümler

12
Sınıflandırma

Uygun
Telif Hakkı

© Improzo
Şovun Web Sitesi

Improzone